Oxford Biomedica PLC — Director's Dealing 2016

Dec 5, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9526Q

Oxford Biomedica PLC

05 December 2016

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

1	Issuer	Oxford BioMedica PLC
2	Reason for notification	Notification relates to DTR 3.1.2R
3	Name of PDMR	Martin Diggle
4	Connected person	Notification relates to following connected persons: Vulpes Life Sciences Fund
5	Notification in respect of	Notification in respect of holdings of persons in 4 above
6	Description of shares	Oxford BioMedica PLC ordinary shares of 1p each
7	Name of registered shareholders and number of shares	Vulpes Life Sciences Fund - 575,850,000 shares
8	Nature of transaction	Acquisition
9	Number of shares acquired	Vulpes Life Sciences Fund - 4,082,333 shares
10	Percentage of issued class acquired	Vulpes Life Sciences Fund - 0.13%
11	Shares disposed	N/A
12	Percentage of issued class disposed	N/A
13/14	Price per share of transactions, and date	Vulpes Life Sciences Fund 4,082,333 shares @ £0.0357 , 02 Dec 2016
15	Total holding following notification and total percentage holding following notification	Vulpes Life Sciences Fund - 546,599,000 shares 17.70% Vulpes Testudo Fund - 33,333,333 shares 1.08%
16	Date issuer informed	05 Dec 2016
23	Any additional information	None
24	Contact name and telephone number	T. Watts, Chief Financial Officer Oxford BioMedica +44 (0)1865 783000

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHGCBDDGSGBGLU